↓ Skip to main content

Benzodiazepines versus placebo for panic disorder in adults

Overview of attention for article published in Cochrane database of systematic reviews, March 2019
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (93rd percentile)
  • Good Attention Score compared to outputs of the same age and source (78th percentile)

Mentioned by

news
1 news outlet
policy
1 policy source
twitter
37 X users
facebook
2 Facebook pages
wikipedia
2 Wikipedia pages

Citations

dimensions_citation
49 Dimensions

Readers on

mendeley
380 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Benzodiazepines versus placebo for panic disorder in adults
Published in
Cochrane database of systematic reviews, March 2019
DOI 10.1002/14651858.cd010677.pub2
Pubmed ID
Authors

Johanna Breilmann, Francesca Girlanda, Giuseppe Guaiana, Corrado Barbui, Andrea Cipriani, Mariasole Castellazzi, Irene Bighelli, Simon JC Davies, Toshi A Furukawa, Markus Koesters

X Demographics

X Demographics

The data shown below were collected from the profiles of 37 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 380 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 <1%
Unknown 379 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 45 12%
Student > Bachelor 40 11%
Researcher 28 7%
Student > Doctoral Student 25 7%
Unspecified 23 6%
Other 83 22%
Unknown 136 36%
Readers by discipline Count As %
Medicine and Dentistry 88 23%
Psychology 34 9%
Unspecified 26 7%
Nursing and Health Professions 23 6%
Pharmacology, Toxicology and Pharmaceutical Science 11 3%
Other 43 11%
Unknown 155 41%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 37. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 September 2023.
All research outputs
#1,116,698
of 25,806,763 outputs
Outputs from Cochrane database of systematic reviews
#2,240
of 13,140 outputs
Outputs of similar age
#25,534
of 365,564 outputs
Outputs of similar age from Cochrane database of systematic reviews
#40
of 184 outputs
Altmetric has tracked 25,806,763 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,140 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.9. This one has done well, scoring higher than 82% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 365,564 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 184 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 78% of its contemporaries.